Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
As of today, Ionis Pharmaceuticals(IONS) shares are valued at $81.79. The company's market cap stands at 13.26B, with a P/E ratio of -47.79.
On 2026-01-22, Ionis Pharmaceuticals(IONS) stock moved within a range of $78.89 to $82.19. With shares now at $81.79, the stock is trading +3.7% above its intraday low and -0.5% below the session's peak.
Trading volume for Ionis Pharmaceuticals(IONS) stock has reached 3.66M, versus its average volume of 2.66M.
The stock's 52-week range extends from a low of $23.95 to a high of $86.15.
The stock's 52-week range extends from a low of $23.95 to a high of $86.15.
IONS News
Advertisement What Ionis’ latest update means for shareholders Ionis Pharmaceuticals (IONS) kicked off 2026 by spotlighting 2025 milestones, including US$105...
Ionis Pharmaceuticals (IONS) and Otsuka Pharmaceutical announced that the European Commission has approved Dawnzera in the European Union for the routine preven...